Alemtuzumab Induction in Kidney Transplantation: Clinical Results and Impact on T-Regulatory Cells-Reference-Cited by-同舟云学术

Alemtuzumab Induction in Kidney Transplantation: Clinical Results and Impact on T-Regulatory Cells

Published:2008-11 Issue:9 Volume:40 Page:3223-3228
ISSN:0041-1345
Container-title:Transplantation Proceedings
language:en
Short-container-title:Transplantation Proceedings

Author:

Morales J.,Bono M.R.,Fierro A.,Iñiguez R.,Zehnder C.,Rosemblatt M.,Calabran L.,Herzog C.,Benavente D.,Aguiló J.,Pefaur J.,Alba A.,Ferrario M.,Simon W.,Contreras L.,Buckel E.

Publisher

Elsevier BV

Subject

Transplantation,Surgery

Reference12 articles.

1. Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (Campath-1H);Kirk;Transplantation,2003

2. Campath-1H in pediatric renal transplantation;Bartosh;Am J Transplant,2005

3. Campath-1H induction plus rapamycin monotherapy for renal transplantation: results of a pilot study;Knechtle;Am J Transplant,2003

4. Campath-1H in renal transplantation: the University of Wisconsin experience;Knechtle;Surgery,2005

5. Randomized trial of alemtuzumab for prevention of graft rejection and preservation of renal function after kidney transplantation;Vathsala;Transplantation,2005

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long‐term outcomes of two‐dose alemtuzumab induction in pediatric kidney transplantation;Pediatric Transplantation;2024-04-16

2. Preoperative CD52 Level Predicts Graft Survival following Kidney Transplantation;BioMed Research International;2022-09-16

3. Combined low-dose everolimus and low-dose tacrolimus after Alemtuzumab induction therapy: a randomized prospective trial in lung transplantation;Trials;2021-01-04

4. Autoreactive T cell profiles are altered following allogeneic islet transplantation with alemtuzumab induction and re‐emerging phenotype is associated with graft function;American Journal of Transplantation;2020-09-19

5. An Insight on the Pathogenesis and Treatment of Systemic Lupus Erythematosus;Endocrine, Metabolic & Immune Disorders - Drug Targets;2018-02-13